ÃâÒßѧÊÔÌâ
d'G0m9u2 Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
!'cl"\h 1. Fas(CD95)/FasL
4*Hgv:0?kI 2. common chain of cytokine receptor
F!]lU`z)= 3 . TCR/CD3 complex
4UW_Do 4. negaive selection of thymocytes
&L,nqc\3D5 5. artificial active immune
t+1 %RyKFB 6. anti-idiotypic
-bSSP!f 7. IgSF
U qFv}VsnF 8. Integrin
,v';>.] 9. chemokine
W8KDX_vGJ 10. B7/CD28
l@
\#Ywz ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
rjp-Fw~1w 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
Dk(1}%0U/ 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
n8" .XS 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
;3B1_vo9 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
Te<}*qvD
cM$P`{QrM 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
2&^]k`Aj6D µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
\4-"
L> Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
CkdP #}f 1. B7/CD28
t
]_VG 2. Th1 subset
Od5JG .] 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
$0lD>yu 4. antibody affinity maturation
:F{:Z*Fi0 5. AP-1
q(.:9A*0 6. single chain variable fragment£¨ScFv£©
(<}&DE 7. NK cell receptor
3
%|86:* 8. Zinkernagel-Doherty phenomenon
R)RG[F# 9. Ig fold
PSZL2iGj9V 10. CD40/CD40L
o8-^cP1 ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
I/L_@X<*r
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
;[u%_ 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
2VE9}%i 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
i-6F:\; Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
hnc@ 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
6T#+V37 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
}9W4"e 2) 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
w6W}"Uw Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
P%(O| £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
.b6VQCS~9 Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
p~,]*y:XT 1.Co-stimulators (or co-stimulating molecules)
T
3pmVl 2.NK-kB
P:aJ# 3.Immunoglobulin superfamily
R]btAu;Z 4.antigen-presenting cell (APC)
_G.>+!"2/
5.death domain
By9*1H2R 6.CCR and CXCR
Q&eQQ6b^Ih 7.Lectin (or mitogen)
dRaNzK)M 8.Clusters of differentiation, CD)
5wh|=**/ 9.B7 family
x"{'&J[hx 10.Cytotoxic T lymphocyte, CTL)
3
"Q=Vl" 11.IL-15 and IL-15 receptor (IL-15R)
naw0$kXTA 12.MHC restriction
vOc 9ZE 13.Affinity-chromatography
PX
n;C/ 14.Cyctosprin A, CsA
`P3>S(Tgy 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
$[/&74#0HX ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
HsHB!mQV 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
.%Ta]!0 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
3MY(<TGX 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
B{C??g8/ Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
NX/;+{ ÃâÒßѧרҵ£º
JA'h4AXk 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
7~GB;1n Ïû»¯ÄÚ¿Æ£º
5i1>I=N 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
kMOpi =Z1 ѪҺ²¡Ñ§×¨Òµ£º
Y))u&*RuT0 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
Ar:*oiU Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
]
&i.b+^ (רҵ»ù´¡: ÃâÒßѧ)
l-s!A(l Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
.$%Soyr?, 1. ADCC(antibody dependent cell-mediated cytotoxicity)
}f8Uc+ 2. »·æß¾úËØ(cyclosporin)
7_mw%
|m6@ 3. KIR(killer cell inhibitory receptor)
`(f!*Ru@/z 4. HLDA(human leucocyte differentiation antigen)
)d$glI+ 5. Interleukin 18(IL-18)
;M_o)OS3 6. ÕûºÏËØ(integrin)
M\Z6$<H?U 7. Fas/FasL
jGEt+\"/QJ 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
Sz^5b! 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
)YX 'N<[ 10. Th1/Th2
&Ibu>di4[ 11. »ùÒòÒßÃç(DNAÒßÃç)
h|h>u
^@ 12. chemokines and chemokine receptor
|pmZ.r 13. ÃâÒßÄÍÊÜ
nD)K}4 14. ¹²´Ì¼¤·Ö×Ó
#ceaZn|@m 15. ËÀÍö½á¹¹Óò(death domain)
5o6>T! ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
H]
$)Eg%6 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
j8fpj {hp 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
AwTJJ0> £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
r4QxoaM £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
Rhe Re £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
LNa $
X5` £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
aAA9$ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
w^#L9i'v' Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
|{@8m9JR ÎÊ´ðÌâ(ÿÌâ25·Ö)
{qmdm`V[ 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
g =2Rqi5 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
3Ezy %7 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
x#Q>J"g 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£